QIAseq

WIPO WIPO 2016

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke QIAseq wurde als Wortmarke am 21.10.2016 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 26. November 2018

Markenform Wortmarke
Aktenzeichen 1331808
Registernummer 015543259
Länder Australien Schweiz China Indien Japan Südkorea Russland Singapur Vereinigte Staaten von Amerika (USA)
Basismarke EU Nr. 015543259, 19. Oktober 2016
Anmeldedatum 21. Oktober 2016
Ablaufdatum 21. Oktober 2026

Markeninhaber

Qiagen Str. 1
40724 Hilden
DE

Markenvertreter

Brucknerstr. 20 40593 Düsseldorf DE

Waren und Dienstleistungen

01 Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes; non-medical reagents, enzymes and buffer solutions for scientific and/or medical research use, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits comprising chemicals for sample preparation, modification and manipulation of cells; kits comprising chemicals for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material; kits comprising in particular chemicals for reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing
05 Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, in particular diagnostics, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; chemical, biochemical and biotechnological preparations, in particular reagents, enzymes and buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits containing preparations for medical and veterinary diagnostic purposes, in particular for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing
09 Scientific apparatuses, instruments and devices, as well as their parts and components included in this class; software for use in scientific and medical research; scientific apparatuses, instruments and devices, software in the area of analysis of nucleic acids, in particular sequencing of nucleic acids
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
21. November 2018 2018/47 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
25. Juni 2018 2018/26 Gaz CN Ablehnung
12. Januar 2018 2018/4 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
12. Januar 2018 2018/3 Gaz CH Ablehnung
21. November 2017 2017/48 Gaz RU Ablehnung
09. November 2017 2017/46 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
09. Oktober 2017 2017/41 Gaz IN Ablehnung
05. September 2017 2017/36 Gaz KR Ablehnung
03. August 2017 2017/31 Gaz SG Ablehnung
01. Juni 2017 2017/22 Gaz JP Ablehnung
24. Mai 2017 2017/21 Gaz AU Ablehnung
04. März 2017 2017/10 Gaz US Ablehnung
21. Oktober 2016 2017/6 Gaz EM Eintragung

ID: 141331808